Abstract
Intestinal pseudoobstruction has been reported as a paraneoplastic manifestation of several cancers, including those of gastrointestinal tract. Octreotide, a somatostatin analogue, has been used successfully in the treatment of idiopathic and scleroderma-associated intestinal pseudoobstruction. We report a 65-year-old man with carcinoma stomach presenting with intestinal pseudoobstruction, which responded to octreotide.
MeSH terms
-
Adenocarcinoma / complications
-
Adenocarcinoma / diagnostic imaging
-
Adenocarcinoma / drug therapy*
-
Aged
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Gastrointestinal Agents / therapeutic use*
-
Humans
-
Intestinal Pseudo-Obstruction / etiology*
-
Male
-
Octreotide / therapeutic use*
-
Radiography
-
Stomach Neoplasms / complications
-
Stomach Neoplasms / diagnostic imaging
-
Stomach Neoplasms / drug therapy*
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Gastrointestinal Agents
-
Octreotide